The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 5.88, with a high estimate of 13.00 and a low estimate of 3.00. The median estimate represents a -2.25% decrease from the last price of 6.01.
The current consensus among 7 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.68
Reporting Date May 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.